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Binding studies indicate that ciguatoxin and brevetoxin allosterically enhance in a very similar way the bind- 
ing of PHlbatrachotoxinin A 20-a-benzoate to the neuronal Na+ channel protein. Moreovr ciguatoxin com- 
petitively inhibits the binding of PHlbrevetoxin-3 to rat brain membranes. The affinity of ciguatoxin for 
the Na+ channel is at least 2&50-times higher than that of brevetoxin. These results indicate that ciguatoxin 
and brevetoxins act at the same binding site on the sodium channel. 
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1. INTRODUCTION 
Ciguatoxin is the principal toxin involved in 
ciguatera. Ciguatera is a type of ichthyosarcotox- 
ism caused by the ingestion of toxic individuals of 
many species of fishes associated with coral reefs. 
Ciguatera syndromes typically include both 
gastrointestinal and neurological symptoms [l]. 
Ciguatoxin is biosynthesized by the benthic 
dinoflagellate Gambierdiscus toxicus which 
adheres to dead coral surfaces and bottom- 
associated algae [2]. CgTx, one of the most toxic 
compounds known, has a molecular mass of 
1112 Da and is of polycyclic ethereal nature [3] as 
also reported for PbTxs that are produced by the 
dinoflagellate Ptychodiscus brevis [4]. PbTxs 
cause massive fish fatality, neurotoxic shellfish 
poisoning and contact irritation of the human skin 
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[5]. The aerosol of the toxin induces in man such 
symptoms as non-productive cough, shortness of 
breath, tearing of the eyes, a burning sensation of 
the conjunctiva, rhinorrhea and sneezing and may 
cause wheezing in persons predisposed to asthma 
[6]. While the exact structure of PbTxs is well 
known [4], the structure of CgTx is still unknown. 
The independent analysis of the mode of action of 
these two types of marine toxins led to the conclu- 
sion that both CgTx and PbTxs act on the voltage- 
dependent Na+ channel [7-111. This paper shows 
that CgTx and PbTxs act at the same binding site 
on the Na+ channel protein. 
2. MATERIALS AND METHODS 
2.1. Materials 
(3H]BTX-B and NaB3H4 were obtained from 
DuPont de Nemours-NEN (Paris, France). TTX 
was from Sankyo (Tokyo, Japan) and veratridine 
from Sigma. The pyrethroid RU 39568 was kindly 
provided by Dr M. Roche (Procida-Roussel-Uclaf, 
Marseilles, France). As2 was purified according to 
Schweitz et al. [ 121. CgTx was prepared as de- 
scribed [7]. [3H]PbTx-3 was prepared from PbTx-2 
and purified as described [13,14]. The labeled tox- 
in had a specific radioactivity of 0.65 Ci/mmol. 
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2.2. Binding assays 
Binding of [3H]BTX-B was carried out at 22°C 
using rat brain membranes as described [15]. 
Binding was measured in the absence or presence 
of 40 PM Asz. The effects of increasing concentra- 
tions of PbTx-2 or CgTx on [3H]BTX-B binding 
were measured by the rapid filtration method on 
GF/C glass fiber filters. The non-specific binding 
component was measured in the presence of 
100 PM veratridine. 
Binding of [3H]PbTx-3 was measured using the 
same rapid filtration technique and the same buf- 
fer as for [3H]BTX-B binding. A large decrease of 
non-specific binding to the filters was obtained by 
pre-treating them with 0.1% polyethyleneimine 
and by using polyethylene tubes with low protein 
adsorption capacity. In inhibition experiments of 
the binding of 25 nM [3H]PbTx-3 by increasing 
concentrations of PbTx-2 or CgTx the incubation 
time was of 2 h at 4°C. Final measurements were 
made by filtration of two aliquots of 200 ~1 of an 
incubation medium (500 ~1) containing 130 mM N- 
methylglucamine, 5.4 mM KCl, 0.8 mM MgS04, 
1 mg/ml BSA, 50 mM Hepes-Tris buffer, pH 7.4, 
and 300-400 pg of rat brain membranes. Radioac- 
tivity was measured using Biofluor (NEN) on a 
Packard Tricarb 3350 spectrophotometer. Ki 
values for CgTx and PbTx-2 could be obtained us- 
ing the relationship Ki = K&l + [L/&l where 
Ko.5 was the inhibitor concentration that decreased 
the specific binding of [3H]PbTx-3 by 50%, L was 
the concentration of [3H]PbTx-3 used in the ex- 
periment, and & was the equilibrium dissociation 
constant of [3H]PbTx-3 obtained with the same 
material [ 141. In direct binding experiments in- 
creasing concentrations of [3H]PbTx-3 were used 
to saturate the binding sites of the toxin in the 
same conditions of incubation as above in the 
presence or absence of 0.2 ng/ml of CgTx. 
Dissociation kinetics of the [3H]PbTx-3-receptor 
complex were followed by diluting the incubation 
medium lo-fold after 2 h of incubation at 4°C 
with 25 nM [3H]PbTx-3. The dilution was 
monitored in the absence or presence of the same 
concentration of 0.2 ng/ml of CgTx. 
3. RESULTS AND DISCUSSION 
Both PbTxs [8] and CgTx [7] are effecters of the 
voltage-dependent Na+ channel. Electrophysiolog- 
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ical properties of their action seem to be very 
similar [7,10] and both toxins stimulate 22Na+ in- 
flux through TTx-sensitive Na+ channels in ex- 
citable cells in culture [7,8]. Moreover, both toxins 
have been claimed [7,8] to have receptor sites 
distinct from those previously identified for the 
large number of other toxins that are also known 
to be specific for the Na+ channel (table 1). 
Therefore the question naturally arises to know 
whether the two toxins can be active on the same 
receptor site as previously observed for other toxin 
families including TTx and saxitoxin [16] (table 1) 
or veratridine, aconitine, grayanotoxins and 
batrachotoxin [17] (table 1). 
The properties of the PbTx receptor have recent- 
ly been identified using [3H]PbTx-3 [ 141. Moreover 
PbTx binding to its receptor is known to 
allosterically alter the binding of [3H]BTX-B in the 
direction of an enhancement of the binding activity 
because of a PbTx-induced increase of the affinity 
of [3H]BTX-B at its own binding site [8]. 
Results presented in fig.1 show that both CgTx 
and PbTx enhance [3H]BTX-B binding to brain 
membranes (fig.1). In the absence of As2, CgTx 
Table 1 
Neurotoxin receptor sites associated with the sodium 
channel 
Receptor 
site 
1 
Ligand 
tetrodotoxin 
saxitoxin 
Physiological 
effect 
block transport 
2 batrachotoxin produce 
veratridine persistent 
aconitine activation 
grayanotoxin 
3 cu-scorpion toxins inhibit inactivation 
sea anemone toxins enhance persistent 
activation 
4 &scorpion toxins repetitive firing 
shift activation 
5 brevetoxins 
ciguatoxin 
repetitive firing 
enhance persistent 
activation 
6 pyrethroids 
DDT 
repetitive firing 
enhance persistent 
activation 
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Fig.l. Enhancement of [3H]BTX-B binding to rat brain 
membrane by CgTx and PbTx-2. (Inset) Comparison of 
the effect of As2, CgTx and PbTx-2 on the binding of 
2 nM of [3H]BTX-B to rat brain membranes. (Main 
panel) [3HIBTX-B (2 nM) was incubated with rat brain 
membranes (300/~g/ml) in the absence (n ,©) or in the 
presence ( ' , . )  of 40/zM As2 with increasing 
concentration of CgTx ( - ,  n) or PbTx-2 (o,©). After 
1 h of incubation at 22°C, two aliquots were filtered 
through GF/C filters and radioactivity measured. Non- 
specific binding was measured in the presence of 100/zM 
veratridine (*). 
and PbTx-2 produced a 2-fold enhancement of the 
binding of [3H]BTX-B as also observed for As2 
alone (control point). In the presence of 40/~M AS2 
the enhancement was higher and reached values of 
6- and 7-fold for PbTx-2 and CgTx, respectively 
(inset fig. 1). Dose-response curves for the enhanc- 
ing effect of PbTx-2 and CgTx on [3H]BTX-B 
binding gave K0.5 values of 50 nM (45 ng/ml) for 
PbTx-2 and 0.9 ng/ml (0.8 nM) for CgTx (fig.l, 
main panel). Synergies of the two toxins with As2 
and pyrethroids were also very similar. 
CgTx, like PbTx-2, inhibited [3H]PbTx binding 
to the Na ÷ channel (fig.2). The inset of fig.2 shows 
that the binding of [~H]PbTx-3 was increased in 
the presence of 40/zM As2 (2-fold), but also in the 
presence of 10/zM of the pyrethroid RU 39568 
(1.8-fold) and in the presence of a mixture of these 
two Na ÷ channel effectors (4.6-fold). This specific 
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Fig.2. Effect of Na ÷ channel neurotoxins on the binding 
of [3H]PbTx-3 to rat brain membranes. (Inset) The 
binding of 25 nM [~H]PbTx-3 in the presence of 40/zM 
As2, 10/zM RU 39568, 40/zM Asz + 10/~M RU 39568, 
40/zM As2 + 10/zM RU 39568 + 10/~M PbTx-2, 1/zM 
TTX or 100/zM veratridine were compared and the 
efficiency of these drugs to modify this binding was 
measured by radioactivity bound relative to control 
experiment. (Main panel) Inhibition of the binding of 
[3H]PbTx-3 by CgTx and PbTx-2. In the conditions of 
maximal stimulation of the [3H]PbTx-3 binding (40/zM 
As2 + 10/zM RU 39568), CgTx ( i)  and PbTx-2 (o) 
inhibit specific binding of [3H]PbTx-3 with increasing 
concentration of these toxins. After 2 h at 4°C of 
incubation, two aliquots were filtered through GF/C 
filters and radioactivity measured. 
binding of [3H]PbTx-3 was totally inhibited by 
10/zM PbTx-2. TTx and veratridine that are 
known to bind to different receptor sites did not 
significantly modify the specific binding of 
[3H]PbTx-3. The main panel of fig.2 shows that 
the specific binding of [3H]PbTx-3 measured in the 
presence of both As2 and RU 39568 is inhibited by 
increasing concentrations of CgTx or PbTx-2 with 
Ko.5 values of 1.4 ng/ml (1.2 nM) and 45 ng/ml 
(50 nM), respectively. The corresponding cal- 
culated Ki values were 0.16 ng/ml (0.14 nM) for 
CgTx and 5 ng/ml (5.6 nM) for PbTx-2. The only 
difference between the two toxins is potency. CgTx 
appeared to be much more potent han PbTx. The 
same difference in potency was also seen by com- 
paring the toxicities of these two compounds using 
the same type of intraperitoneal injection in mice. 
The LDs0 for CgTx was 0.45/zg/kg (4 × 
10 -l° mol/kg) [3] and the LDso for PbTx-2 was 
180/zg/kg (2 x 10 -7 mol/kg) [18]. In such assays 
CgTx was 400-500-fold more active than PbTx-2. 
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Fig.3. Competitive inhibition of [3H]PbTx-3 binding by 
CgTx. The binding of [3H]PbTx-3 was carried out in the 
presence of 40pM As2 and 1OpM RU 39568 (0). The 
effect of 0.2 ng/ml of CgTx was measured under the 
same conditions (0). Incubation conditions are those 
described for fig.2. (Inset) The remaining binding of 
[3H]PbTx to its sites as a function of time after a IO-fold 
dilution in the absence (0) or presence (0) or 0.2 ng/ml 
of CgTx. The dilution was carried out after 2 h 
incubation of 25 nM [3H]PbTx-3 at 4°C on rat brain 
membranes. In the dilution medium, concentrations of 
As2 and RU 39568 were maintained to eliminate any 
possible modification of the conformation of their 
receptors that could modify the interaction of PbTx to 
its own binding sites. 
In the experiments reported here CgTx had a 
30-50-fold higher affinity for the Na+ channel 
than PbTx-2. The high affinity of CgTx for the 
Na+ channel is consistent with the observation that 
the toxin is active on isolated guinea pig ileum at 
concentrations as low as a few picomoles [19]. 
Plots presented in fig.3 show [3H]PbTx-3 binding 
to a single family of binding sites with a Kd of 
17 nM that is slightly higher than previously 
reported [14], and a B,,, value of 6.0 pmol/mg of 
protein. In the presence of 0.2 ng/ml of CgTx the 
B mm value was almost identical 6.4 pmol/mg of 
protein whereas the Kd value was significantly 
3.58 
decreased to 63 nM (a 3.7-fold lowering). 
Therefore CgTx seems to act as a competitive in- 
hibitor at the PbTx binding site. Analysis of 
dissociation kinetics of the [3H]PbTx-3-receptor 
complex confirmed this view (inset of fig.3). The 
half-life of dissociation of the PbTx-receptor com- 
plex (f1/2 - 4.0 min) was almost the same in the 
presence and absence of CgTx. 
Results presented in this paper not only show 
that PbTxs and CgTx are to be put in the same 
class of compounds acting on the Na+ channel, 
they also confirm that this class of toxins binds to 
a specific receptor distinct from all other toxin 
receptors. Stimulating effects on [3H]BTx binding 
show that the CgTx/PbTx receptor is distinct from 
the receptor of toxins of class 2 (table l), synergism 
with sea anemone toxins and pyrethroids show that 
the CgTx/PbTx receptor is distinct from receptors 
for toxins of class 3 and class 6 (table 1). It has 
been shown [7] that CgTx had no interaction at 
sites 1 and 4 that are those recognized by TTx and 
P-scorpion toxins, respectively. 
All these results taken together indicate that 
CgTx and PbTx share a common and unique 
receptor site on the voltage-dependent Na+ chan- 
nel (table 1). CgTx because of its very high affinity 
could become a new useful pharmacological tool 
as are TTx, saxitoxin, BTx and Tityus serrulatus 
toxin y [20] to study the Na+ channel. Moreover 
assays which have been described in this paper 
could be used analytically for the detection of 
CgTx in fishes associated with coral reefs. 
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